Literature DB >> 7613800

Psychological reactions in men screened for prostate cancer.

O Gustafsson1, T Theorell, U Norming, A Perski, M Ohström, C R Nyman.   

Abstract

OBJECTIVE: To investigate the possible negative psychological impact of screening for prostate cancer with special focus on the impact of false positive and true positive test results. SUBJECTS AND METHODS: As part of an early detection study for prostate cancer psychological and psychophysiological reactions to various phases of the diagnostic procedures were examined in 2400 randomly selected men divided into various groups. Their psychophysiological reactions were assessed by measurements of serum cortisol and their psychological reactions by questionnaires directed at determining emotional states and sleep disturbance. In a stratified sample of the population (100 men) measurements were made at the time of the screening examination and again 2 weeks later. In patients undergoing biopsy (307 men) measurements were made 2 weeks after screening, but before they were informed of the biopsy results, and again 4 and 16 weeks after screening.
RESULTS: Serum cortisol levels at the screening examination were higher than corresponding levels of a comparable sample of Swedish men during normal daily activity, indicating that an invitation to examination for prostate cancer per se might create emotional stress. Two weeks after the screening the elevated levels had decreased to normal. The highest cortisol levels were found in men who had undergone biopsy, immediately before they were informed of the results 2 weeks after screening. After they were informed, cortisol levels fell, regardless of the results of the biopsy. The patterns of emotional state and sleep disturbance were similar except that sleep disturbance was delayed.
CONCLUSION: In screening programmes for prostate cancer it is important to define clearly the high-risk groups to minimize the risk of adverse psychological reactions in those subjects with a low risk of having the disease. The results also emphasize the need to reduce the number of false positive results by choosing diagnostic tests of high specificity. The interval between a test and informing the subject of the results should be minimized to decrease the duration of the increased emotional stress.

Entities:  

Mesh:

Year:  1995        PMID: 7613800     DOI: 10.1111/j.1464-410x.1995.tb07422.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  18 in total

Review 1.  Interventions to improve follow-up of abnormal findings in cancer screening.

Authors:  Roshan Bastani; K Robin Yabroff; Ronald E Myers; Beth Glenn
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

2.  [PSA 2010--the beginning of a new era in early detection of prostate cancer].

Authors:  C Börgermann; M Sieverding; P Fornara; M Graefen; P Hammerer; A Semjonow; F Schröder; H Rübben
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

3.  The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes.

Authors:  Floyd J Fowler; Michael J Barry; Beth Walker-Corkery; Jean-Francois Caubet; David W Bates; Jeong Min Lee; Alison Hauser; Mary McNaughton-Collins
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

Review 4.  The role of anxiety in prostate carcinoma: a structured review of the literature.

Authors:  William Dale; Pinar Bilir; Misop Han; David Meltzer
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

5.  Measurement of prostate specific antigen as screening test for prostate cancer. Trials of treatment are needed before trials of screening.

Authors:  S Sandhu; R Morris; V Matveev; A V Kaisary
Journal:  BMJ       Date:  1996-03-16

6.  Risk perception and psychological morbidity in men at elevated risk for prostate cancer.

Authors:  A G Matthew; T Davidson; S Ochs; K L Currie; A Petrella; A Finelli
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

7.  The effect of video-based education on patient anxiety in men undergoing transrectal prostate biopsy.

Authors:  Huseyin Tarhan; Ozgur Cakmak; Elif Unal; Ilker Akarken; Sitki Un; Rahmi Gokhan Ekin; Ersin Konyalioglu; Cemal Selcuk Isoglu; Ferruh Zorlu
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

8.  Health perceptions in patients who undergo screening and workup for prostate cancer.

Authors:  David A Katz; David F Jarrard; Colleen A McHorney; Stephen L Hillis; Donald A Wiebe; Dennis G Fryback
Journal:  Urology       Date:  2007-02       Impact factor: 2.649

9.  Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result.

Authors:  R C Macefield; C Metcalfe; J A Lane; J L Donovan; K N L Avery; J M Blazeby; L Down; D E Neal; F C Hamdy; K Vedhara
Journal:  Br J Cancer       Date:  2010-04-06       Impact factor: 7.640

10.  [Informed consent for patients on early recognition of prostate carcinoma is insufficient].

Authors:  C Börgermann; F vom Dorp; R Rossi; M Schenck; H-J Luboldt; H Rübben
Journal:  Urologe A       Date:  2009-09       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.